NCT00081159: Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases |
|
|
| Completed | 2 | 80 | US | Doxorubicin hydrochloride, Adriamycin PFS, Adriamycin RDF, Adriamycin, Rubex, Goserelin acetate, Zoladex, Leuprolide acetate, Lupron Depot, Zoledronic acid, Zoledronate, Zometa, orchiectomy, strontium chloride Sr, Sr-89, Strontium-89, Mestastron | M.D. Anderson Cancer Center, National Cancer Institute (NCI) | Metastatic Cancer, Prostate Cancer | 09/14 | 09/14 | | |
NCT01076335: Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate Cancer |
|
|
| Completed | 2 | 40 | US | Neoadjuvant Hormonal Therapy, Leuprolide Acetate, Goserelin Acetate, Docetaxel, Taxotere | M.D. Anderson Cancer Center, National Cancer Institute (NCI) | Prostate Cancer | 06/15 | 06/15 | | |
